Investment ThemesDetailed Quotes
Gene Editing
Watchlist
Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
- 1472.372
- -30.216-2.01%
Close Oct 18 16:00 ET
1502.987High1466.511Low
1502.589Open1502.589Pre Close14.63MVolume7Rise73.25P/E (Static)1.40BTurnover--Flatline1.03%Turnover Ratio176.96BMarket Cap3Fall174.82BFloat Cap
Constituent Stocks: 10Top Rising: CRBU+3.09%
Hope so. Big position here under $0.60
GLTA.
This legal step underscores Sangamo's efforts to ensure its corporate actions comply with legal standards and underscores the company's commitment to its stockholders' interests. The outcome of the hearing will determine the definitive status of the common stock increase amendment. This information is based on a press release statement
Sangamo seeks court validation for stock amendment By Investing.com
No comment yet